Company Profile
Deyang Chengchuang is specialized in the research and development of API , pharmaceutical intermediates, technical service and transformation . We can do all types of reactions and have both kilograms and tons of large-scale production capacity. Our core team involves five Researchers with master's degree and above, three senior Scientists with more than a decade of experience in pharmaceutical research and development. Our main business scope includes the production of innovative drugs (NCEs) and patent medicines (chemical synthesis APIs and intermediates) imitation, custom APIs , pharmaceutical intermediates and impurities. We have long-term friendly and cooperative relations with domestic and foreign Pharmaceutical manufacturers. Deyang Chengchuang always upholds the company philosophy "integrity first, technology innovation" and has established strict system to control the quality of products. Warmly welcome domestic and foreign pharmaceutical scientists and sales business elite to join us or discuss cooperation matters!
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(4-methylpiperazin-1-yl)-4-(o-tolyl)nicotinamide |
3-Pyridinecarboxamide,4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-;4-(2-Methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinecarboxamide;6-(4-Methylpiperazin-1-yl)-4-o-tolylnicotinamide |
342417-01-0 | Inquiry | |
2-(3,5-bis(trifluoroMethyl)phenyl)-2-Methyl propanoic acid |
2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoic acid;2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropanoic acid;2-(3,5-bis(trifluoroMethyl)phenyl)-2-Methyl propanoic acid;MFCD09032572;2-[3,5-bis(trifluoromethyl)phenyl]-2-methylpropionic acid;Benzeneacetic acid, alpha,alpha-dimethyl-3,5-bis(trifluoromethyl)-;2-(3,5-Bis(trifluoromethyl)phenyl)-2-methylpropionic acid;Netupitant ITS-5;2-(3,5-Bis-trifluoromethyl-phenyl)-;2-(3,5-Bis-trifluoromethyl-phenyl)-2-methyl-propionic acid |
289686-70-0 | Inquiry | |
3ALPHA-HYDROXY-7-OXO-5BETA-CHOLANIC ACID |
Cholan-24-oic acid,3-hydroxy-7-oxo-,(3α,5β)-;5β-Cholan-24-oic acid,3α-hydroxy-7-oxo-;5β-Cholanic acid,3α-hydroxy-7-oxo-;(3α,5β)-3-Hydroxy-7-oxocholan-24-oic acid;3α-Hydroxy-7-oxo-5β-cholanoic acid;7-Ketochenodeoxycholic acid;7-Ketolithocholic acid;7-Oxolithocholic acid;7-Oxo-3α-hydroxycholan-24-oic acid;3α-Hydroxy-7-oxo-5β-cholanic acid;5β-Cholanic acid-3α-ol-7-one;3α-Hydroxy-7-oxo-5β-cholan-24-oic acid;Nutriacholic acid;NSC 226118;7-keto-Lithocholic acid;3α-Hydroxy-7-oxo-5β-cholic acid;3α-Hydroxy-7-keto-5β-cholanic acid;7K-LCA;3α-Hydroxy-7-keto-5β-cholan-24-oic acid;keto-Lithocholic acid;98646-38-9 |
4651-67-6 | Inquiry | |
6-Chloromethyluracil |
2,4(1H,3H)-Pyrimidinedione,6-(chloromethyl)-;Uracil,6-(chloromethyl)-;6-(Chloromethyl)-2,4(1H,3H)-pyrimidinedione;6-(Chloromethyl)uracil;6-(Chloromethyl)pyrimidine-2,4(1H,3H)-dione;6-(Chloromethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione;Uracyl chloride |
18592-13-7 | Inquiry | |
Afatinib |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;915958-11-1 |
439081-18-2 | Inquiry | |
Apixaban |
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide,4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-;4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide;BMS 562247-01;Apixaban;Eliquis;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide;1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide |
503612-47-3 | Inquiry | |
AZD9291 |
2-Propenamide,N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-;N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;AZD 9291;Osimertinib;Tagrisso;1610419-47-0 |
1421373-65-0 | Inquiry | |
Canagliflozin |
D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-,(1S)-;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;TA 7284;JNJ 28431754;Canagliflozin;JNJ 28431754AAA;JNJ 24831754ZAE;Invokana;1-(β-D-Glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;2169850-08-0 |
842133-18-0 | Inquiry | |
Empagliflozin int. |
Furan, 3-[4-[(5-broMo-2-chlorophenyl)Methyl]phenoxy]tetrahydro-, (3S)-;(3S)-3-[4-[(5-Bromo-2-chlorophenyl)methyl]phenoxy]tetrahydro-furan;(S)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran;EMpagliflozin InterMediate;Empagliflozin Intermediate2;(3S)-3-[4-[(5-bromo-2-chlorophenyl)methyl]phenoxy]oxolane;(3S)-3-(4-(5-bromo-2-chlorobenzyl) methyl]phenoxy]tetrahydro-furan;(35)-3-[4-[(5-Bromo-2-chlorophenyl)methyllphenoxyltetrahydro-furan |
915095-89-5 | Inquiry | |
losmapimod |
3-Pyridinecarboxamide,6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-;6-[5-[(Cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide;6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)nicotinamide;GW 856553X;Losmapimod;GSK-AHAB;SB 856553;GW 856553;1201684-97-0 |
585543-15-3 | Inquiry | |
Netupitant |
Benzeneacetamide,N,α,α-trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)-;N,α,α-Trimethyl-N-[4-(2-methylphenyl)-6-(4-methyl-1-piperazinyl)-3-pyridinyl]-3,5-bis(trifluoromethyl)benzeneacetamide;Netupitant;Ro 67-31898/000;2-[3,5-Bis(trifluoromethyl)phenyl]-N-[6-(4-methylpiperazin-1-yl)-4-o-tolylpyridin-3-yl]-N-methylisobutyramide;2-[3,5-Bis(trifluoromethyl)phenyl]-N,2-dimethyl-N-[4-(2-methylphenyl)-6-(4-methylpiperazin-1-yl)pyridin-3-yl]propanamide |
290297-26-6 | Inquiry | |
obeticholic acid |
Cholan-24-oic acid,6-ethyl-3,7-dihydroxy-,(3α,5β,6α,7α)-;(3α,5β,6α,7α)-6-Ethyl-3,7-dihydroxycholan-24-oic acid;6-Ethylchenodeoxycholic acid;3α,7β-Dihydroxy-6α-ethyl-5β-cholan-24-oic acid;Obeticholic acid;INT 747;6α-Ethylchenodeoxycholic acid;6-ECDCA;Ocaliva |
459789-99-2 | Inquiry | |
Olaparib |
1(2H)-Phthalazinone,4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-;Piperazine,1-(cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]-;4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone;Olaparib;KU 59436;AZD 2281;KU 0059436;4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one;Lynparza;AZD2281;AZD-2281;937799-91-2;1021843-02-6;894104-70-2 |
763113-22-0 | Inquiry | |
Olaparib int |
Benzoic acid,5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluoro-;5-[(3,4-Dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoic acid;2-Fluoro-5-(4-oxo-3,4-dihydrophthalazin-1-ylmethyl)benzoic acid;2-Fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoic acid;2361416-85-3 |
763114-26-7 | Inquiry | |
Rivaroxaban |
2-Thiophenecarboxamide,5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;Rivaroxaban;BAY 59-7939;5-Chloro-N-[[(S)-3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]-thiophene-2-carboxamide;Xarelto;5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl]methyl]-2-thiophenecarboxamide;5-Chloro-N-([(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl]-methyl)-2-thiophenecarboxamide;(S)-Rivaroxaban;869880-21-7;931117-62-3;1807854-46-1 |
366789-02-8 | Inquiry | |
Safinamide mesilate |
Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(2S)-,methanesulfonate (1:1);Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(S)-,monomethanesulfonate;Propanamide,2-[[[4-[(3-fluorophenyl)methoxy]phenyl]methyl]amino]-,(2S)-,monomethanesulfonate;PNU 151774E;NW 1015;Safinamide mesylate;(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide methanesulfonate;Safinamide methanesulfonate;EMD 1195686 mesylate;Xadago |
202825-46-5 | Inquiry | |
ticagrelor |
1,2-Cyclopentanediol,3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-,(1S,2S,3R,5S)-;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol;Ticagrelor;AZD 6140;AR-C 126532XX;Brilinta;Brilique;Triafluocyl;Possia;AZD6140;AZD-6140;477283-75-3;873203-45-3;1215268-22-6;1310481-20-9;2588537-79-3 |
274693-27-5 | Inquiry |
CONTACT INFORMATION
Sign In for Details